Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Plasma serotonin in autism.

Connors SL, Matteson KJ, Sega GA, Lozzio CB, Carroll RC, Zimmerman AW.

Pediatr Neurol. 2006 Sep;35(3):182-6.

PMID:
16939857
2.

HL-60 cell growth-conditioned medium is an effective inducer of myeloperoxidase expression in K-562 human leukemia cells.

Baker EJ, Gerard DA, Bamberger EG, Lozzio CB, Ichiki AT.

Leuk Res. 2002 Nov;26(11):1017-25.

PMID:
12363471
3.

Simultaneous flow cytometric measurement of K-562 megakaryocytic differentiation and CD56+ large granular lymphocyte cytotoxicity.

Baker EJ, Ichiki AT, Day NE, Andrews RB, Bamberger EG, Lozzio CB.

J Immunol Methods. 2001 Jul 1;253(1-2):37-44.

PMID:
11384667
4.

PMA-treated K-562 leukemia cells mediate a TH2-specific expansion of CD4+ T cells in vitro.

Baker EJ, Ichiki AT, Hodge JW, Sugantharaj D, Bamberger EG, Lozzio CB.

Leuk Res. 2000 Dec;24(12):1049-57.

PMID:
11077119
5.

Differential regulation of interleukin-1alpha and interleukin-1beta in K-562 cells.

Ichiki AT, Langenberg M, Baker EJ, Hodge JW, Bamberger EG, Gerard DA, Lozzio CB.

J Interferon Cytokine Res. 1998 Dec;18(12):1045-50.

PMID:
9877448
6.

Position statement on interphase in situ hybridization prenatal diagnosis. Report of the Southeastern Regional Genetics Group (SERGG).

Lubs HA, Elsas LJ 2nd, Tharapel AT, Buchanan PD, Finley WH, Lozzio CB, Pelias MZ.

Am J Med Genet. 1993 Jun 1;46(4):478. No abstract available.

PMID:
8357030
7.

Use of a molecular genetic approach to diagnosing the fragile X genotype.

Potter NT, Lozzio CB, Anderson IJ, Bowlin ES, Matteson KJ.

J Pediatr. 1992 Sep;121(3):385-90.

PMID:
1517912
8.

Cell death in the human leukemia cell line, K-562, induced by antiserum and monoclonal antibodies.

Wust CJ, Hodge JW, Ichiki AT, Lozzio CB.

Leuk Res. 1991;15(6):497-506.

PMID:
1713636
9.

Antibodies to specific cell surface antigens of a human leukemia cell line, K-562, transduce negative growth signals.

Hodge JW, Wust CJ, Ichiki AT, Lozzio CB.

Ann N Y Acad Sci. 1991;628:165-8. No abstract available.

PMID:
1712551
10.

Interaction between selenium and zinc in the pathogenesis of anencephaly and spina bifida.

Zimmerman AW, Lozzio CB.

Z Kinderchir. 1989 Dec;44 Suppl 1:48-50.

PMID:
2696286
11.

Involvement of cytoplasmic membranes in the non-lytic infection of K-562 cells by Semliki Forest virus.

Brady BE, Gerard D, Wust CJ, Lozzio CB, Brown A.

Eur J Cell Biol. 1989 Apr;48(2):203-11.

PMID:
2545448
12.

Detection of surface differences between closely related cell populations by partitioning. Cultured K-562 cell sublines.

Walter H, Krob EJ, Al-Romaihi FA, Johnson D, Lozzio CB.

Cell Biophys. 1988 Dec;13(3):173-87.

PMID:
2465826
13.

Chromosome breakage in control and fragile X subjects using folate-deficient culture conditions.

Butler MG, Joseph GM, Rames LJ, Cacheiro N, Lozzio CB.

Hum Genet. 1988 Apr;78(4):383. No abstract available.

14.

Lowered susceptibility of K-562 cells treated with gamma interferon in serum-free medium to natural killer cell-mediated cytolysis.

Ichiki AT, Sugantharaj DG, Hudson CS, Gerard DA, Barnhill MA, Bamberger EG, Wust CJ, Fuhr JE, Lozzio CB.

Nat Immun Cell Growth Regul. 1988;7(5-6):297-304.

PMID:
3146698
15.

Do some patients with Seckel syndrome have hematological problems and/or chromosome breakage?

Butler MG, Hall BD, Maclean RN, Lozzio CB.

Am J Med Genet. 1987 Jul;27(3):645-9.

16.

Interferon-gamma-induced expression of class I HLA antigens on K-562 cells grown in serum-free medium.

Ichiki AT, Lozzio CB, Barnhill MA, Wust CJ, Bamberger EG, Trent DJ, Lucas PB, Bray JC, Fuhr JE.

J Interferon Res. 1987 Feb;7(1):87-93.

PMID:
3108418
17.

Continuous or modulation expression of hematopoietic cell antigens in sublines of the leukemia cell line, K-562.

Ichiki AT, Lozzio CB, Bamberger EG, Lucas PB, Wust CJ, Fuhr JE.

Leuk Res. 1987;11(4):359-64.

PMID:
3470580
18.

Diversity of cell surface hematopoietic antigens on K-562 sublines identified with monoclonal antibodies.

Ichiki AT, Bamberger EG, Wust CJ, Lozzio CB.

Leuk Res. 1986;10(5):565-74.

PMID:
2940421
19.
20.

Natural killer cell resistance in K-562 cell sublines.

Foster JS, Wust CJ, Lozzio CB, Bamberger EG, Ichiki AT.

Int J Cancer. 1985 Mar 15;35(3):343-9.

PMID:
3855845
21.

Characterization of the Fc(IgG) receptor on the pluripotential leukaemia cell K-562.

Ichiki AT, Wust CJ, Lozzio CB.

Clin Exp Immunol. 1985 Jan;59(1):64-8.

22.

Proliferation and differentiation of human myeloid leukemic cells in immunodeficient mice: electron microscopy and cytochemistry.

Machado EA, Gerard DA, Lozzio CB, Lozzio BB, Mitchell JR, Golde DW.

Blood. 1984 May;63(5):1015-22.

PMID:
6324924
23.

K562 human leukemia cell passages differ in embryonic globin gene expression.

Rowley PT, Ohlsson-Wilhelm BM, Wisniewski L, Lozzio CB, Lozzio BB.

Leuk Res. 1984;8(1):45-54.

PMID:
6199625
25.

Brief clinical report: skeletal dysplasia with short, angulated femora (kyphomelic dysplasia).

Maclean RN, Prater WK, Lozzio CB.

Am J Med Genet. 1983 Feb;14(2):373-80.

PMID:
6837632
26.
27.
28.

Antibody lysis of human hematopoietic cells in the absence of complement and effector cells.

Lozzio CB, Lozzio BB, Wust CJ, Bamberger EG, Golde DW, Minowada J.

Exp Hematol. 1982 Sep;10(8):698-707.

PMID:
6183138
29.

Identification and quantitation of embryonic and three types of fetal hemoglobin produced on induction of the human pluripotent leukemia cell line K-562 with hemin.

Fuhr JE, Bamberger E, Lozzio CB, Lozzio BB, Felice AE, Altay G, Webber BB, Reese AL, Mayson SM, Huisman TH.

Am J Hematol. 1982 Feb;12(1):1-12.

PMID:
6175208
30.

Arrest and extravasation of neoplastic cells. An electron microscopy study of serial sections at sequential stages.

Machado EA, Gerard DA, Mitchell JR, Lozzio BB, Lozzio CB.

Virchows Arch A Pathol Anat Histol. 1982;396(1):73-89.

PMID:
7123846
31.
32.

Human myeloid cell lines.

Lozzio CB, Lozzio BB, Feliu AS, Bamberger EG.

Blood. 1981 May;57(5):979-80. No abstract available.

PMID:
7214026
33.

A multipotential leukemia cell line (K-562) of human origin.

Lozzio BB, Lozzio CB, Bamberger EG, Feliu AS.

Proc Soc Exp Biol Med. 1981 Apr;166(4):546-50. No abstract available.

PMID:
7194480
34.

Cyclic neutropenia. A tale of two brothers and their family.

Lange RD, Crowder CG, Cruz P, Hawkinson SW, Lozzio CB, Machado E, Painter P, Terry W, Jones JB.

Am J Pediatr Hematol Oncol. 1981 Summer;3(2):127-33.

PMID:
6795955
35.

Induction of hemoglobin synthesis in original K 562 cell line.

Fuhr JE, Bamberger EG, Lozzio CB, Lozzio BB.

Blood Cells. 1981;7(2):389-99.

PMID:
6170369
36.

Evaluation of drug-antibody conjugates in the treatment of human myelosarcomas transplanted in nude mice.

Latif ZA, Lozzio BB, Wust CJ, Krauss S, Aggio MC, Lozzio CB.

Cancer. 1980 Mar 15;45(6):1326-33.

PMID:
6928397
37.

Effects of sodium butyrate on human chronic myelogenous leukaemia cell line K562.

Lozzio CB, Lozzio BB, Machado EA, Fuhr JE, Lair SV, Bamberger EG.

Nature. 1979 Oct 25;281(5733):709-10. No abstract available.

PMID:
298333
38.

Absence of erythrocytic components in the original K562 cell line.

Lozzio BB, Lozzio CB.

Int J Cancer. 1979 Oct 15;24(4):513. No abstract available.

PMID:
528074
39.

Philadelphia chromosome-positive acute myeloblastic leukemia.

Krauss S, Sonoda T, Lozzio CB.

J Tenn Med Assoc. 1979 Aug;72(8):586-8. No abstract available.

PMID:
290849
40.

Reproducible metastatic growth of K-562 human myelogenous leukemia cells in nude mice.

Lozzio BB, Machado EA, Lair SV, Lozzio CB.

J Natl Cancer Inst. 1979 Aug;63(2):295-9.

PMID:
287825
41.

Abrogation of the proliferation of human leukemia cells in nude mice by a xenoantiserum.

Latif ZA, Lozzio BB, Lozzio CB, Herberman RB, Wust CJ.

Leuk Res. 1979;3(6):371-8. No abstract available.

PMID:
548652
42.

Properties and usefulness of the original K-562 human myelogenous leukemia cell line.

Lozzio BB, Lozzio CB.

Leuk Res. 1979;3(6):363-70. Review. No abstract available.

PMID:
95026
43.

Correlation of leukemia-associated antigens and Ph1 chromosome in fibroblastlike cells derived from bone marrow.

Lozzio CB, Lozzio BB, Wust CJ, Kim J.

Blood. 1978 Oct;52(4):673-80. No abstract available.

PMID:
99197
44.

Cytotoxicity of a factor from normal and abnormal human spleens for allogenic leukemia cells.

Lozzio BB, Lozzio CB, Bamberger EG.

Am J Hematol. 1978;4(1):57-65.

PMID:
655158
45.

Suppression of human myelosarcoma growth in athymic mice by a primate antiserum.

Lozzio BB, Machado EA, Lair SA, Lozzio CB.

Cancer Treat Rep. 1977 Dec;61(9):1679-84.

PMID:
271518
46.

Characterization of an antigen from the myelogenous leukemia cell line K-562.

Collins JL, Wust CJ, Lozzio BB, Lozzio CB.

J Natl Cancer Inst. 1977 Dec;59(6):1667-74.

PMID:
72824
47.

Development of myelosarcomas from human myelogenous leukemia cells transplanted in athymic mice.

Machado EA, Lozzio BB, Lozzio CB, Lair SV, Aggio MC.

Cancer Res. 1977 Nov;37(11):3995-4002. No abstract available.

48.

Leukemia-associated antigens detected by a nonhuman primate antiserum to a Ph1+ myeologenous leukemia cell line.

Lozzio BB, Lozzio CB, Krauss S, Wust CJ, Girardi A.

Blood. 1977 Jul;50(1):115-24. No abstract available.

PMID:
68791
49.

Properties of the K562 cell line derived from a patient with chronic myeloid leukemia.

Lozzio BB, Lozzio CB.

Int J Cancer. 1977 Jan;19(1):136. No abstract available.

PMID:
264472
50.

Absence of thymus-derived lymphocyte markers in myelogenous leukemia (Ph1+) cell line K-562.

Lozzio CB, Lozzio BB, Yang WK, Ichiki AT, Bamberger EG.

Cancer Res. 1976 Dec;36(12):4657-62.

Supplemental Content

Loading ...
Support Center